Literature DB >> 12650234

Base rates of malingering and symptom exaggeration.

Wiley Mittenberg1, Christine Patton, Elizabeth M Canyock, Daniel C Condit.   

Abstract

Base rates of probable malingering and symptom exaggeration are reported from a survey of the American Board of Clinical Neuropsychology membership. Estimates were based on 33,531 annual cases involved in personal injury, (n = 6,371). disability (n = 3,688), criminal (n = 1,341), or medical (n = 22,131) matters. Base rates did not differ among geographic regions or practice settings, but were related to the proportion of plaintiff versus defense referrals. Reported rates would be 2-4% higher if variance due to referral source was controlled. Twenty-nine percent of personal injury, 30% of disability, 19% of criminal, and 8% of medical cases involved probable malingering and symptom exaggeration. Thirty-nine percent of mild head injury, 35% of fibromyalgia/chronic fatigue, 31% of chronic pain, 27% of neurotoxic, and 22% of electrical injury claims resulted in diagnostic impressions of probable malingering. Diagnosis was supported by multiple sources of evidence, including severity (65% of cases) or pattern (64% of cases) of cognitive impairment that was inconsistent with the condition, scores below empirical cutoffs on forced choice tests (57% of cases), discrepancies among records, self-report, and observed behavior (56%), implausible self-reported symptoms in interview (46%), implausible changes in test scores across repeated examinations (45%), and validity scales on objective personality tests (38% of cases).

Entities:  

Mesh:

Year:  2002        PMID: 12650234     DOI: 10.1076/jcen.24.8.1094.8379

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  50 in total

1.  Neuropathic pain syndrome displayed by malingerers.

Authors:  José L Ochoa; Renato J Verdugo
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

Review 2.  [The "reasonable effort of will" in the expert opinion in social medicine].

Authors:  K Foerster; H Dressing
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

3.  [Negative response bias and the validity of personality profiles in neuropsychiatric assessment].

Authors:  T Merten; E Friedel; G Mehren; A Stevens
Journal:  Nervenarzt       Date:  2007-05       Impact factor: 1.214

Review 4.  Management of pediatric mild traumatic brain injury: a neuropsychological review from injury through recovery.

Authors:  Michael W Kirkwood; Keith Owen Yeates; H Gerry Taylor; Christopher Randolph; Michael McCrea; Vicki A Anderson
Journal:  Clin Neuropsychol       Date:  2007-09-01       Impact factor: 3.535

Review 5.  [Symptom and complaint validation of chronic pain in social medical evaluation. Part I: Terminological and methodological approaches].

Authors:  R Dohrenbusch
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

Review 6.  Illness related deception: social or psychiatric problem?

Authors:  Christopher Bass; Peter W Halligan
Journal:  J R Soc Med       Date:  2007-02       Impact factor: 5.344

7.  [Negative response bias and assessment of uncooperativeness in independent medical evaluations].

Authors:  T Merten
Journal:  Orthopade       Date:  2010-03       Impact factor: 1.087

8.  Effort in college undergraduates is sufficient on the word memory test.

Authors:  Octavio A Santos; Dmitriy Kazakov; Mary K Reamer; Sydney E Park; David C Osmon
Journal:  Arch Clin Neuropsychol       Date:  2014-08-22       Impact factor: 2.813

Review 9.  Test validity and performance validity: considerations in providing a framework for development of an ability-focused neuropsychological test battery.

Authors:  Glenn J Larrabee
Journal:  Arch Clin Neuropsychol       Date:  2014-10-03       Impact factor: 2.813

10.  Disability evaluation of the pain : the present and prospect in Korea.

Authors:  Kyeong-Seok Lee; Jai-Joon Shim; Seok-Mann Yoon; Jae-Won Doh; Il-Gyu Yun; Hack-Gun Bae
Journal:  J Korean Neurosurg Soc       Date:  2009-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.